Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prevention of Venous Thromboembolism After Knee Arthroplasty”

Showing 10 of 0 results

Large-scale testing (Phase 3)Study completedNCT01181102
What this trial is testing

DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty

Who this might be right for
Venous Thromboembolism
Daiichi Sankyo Co., Ltd. 716
Testing effectiveness (Phase 2)Study completedNCT06454630
What this trial is testing

A Trial to Learn How Well REGN7508 Works for Preventing Blood Clots After a Knee Replacement in Adult Participants

Who this might be right for
Venous Thromboembolism
Regeneron Pharmaceuticals 179
Testing effectiveness (Phase 2)Study completedNCT00375609
What this trial is testing

Factor Xa Inhibitor, PRT054021, Against Enoxaparin for the Prevention of Venous Thromboembolic Events (EXPERT)

Who this might be right for
Thromboembolism
Portola Pharmaceuticals 215
Large-scale testing (Phase 3)Looking for participantsNCT07015905
What this trial is testing

REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults

Who this might be right for
Venous Thromboembolism (VTE)
Regeneron Pharmaceuticals 2,000
Testing effectiveness (Phase 2)Study completedNCT03088358
What this trial is testing

Safety and Efficacy of TeaRx Xa Factor Direct Inhibitor Versus Enoxaparin as a Venous Thromboembolic Events (VTE) Prevention Following Total Knee Replacement

Who this might be right for
Total Knee Replacement
TeaRx LLC 200
Not applicableStudy completedNCT00831714
What this trial is testing

Xarelto for VTE Prophylaxis After Hip or Knee Arthroplasty

Who this might be right for
Venous Thromboembolism
Bayer 19,076
Testing effectiveness (Phase 2)Study completedNCT05618808
What this trial is testing

A Trial to Learn How Well REGN9933 Works for Preventing Blood Clots After Knee Replacement Surgery in Adult Participants

Who this might be right for
Venous Thromboembolism
Regeneron Pharmaceuticals 373
Post-approval studies (Phase 4)Study completedNCT00362492
What this trial is testing

Safety Study of Stopping Thromboprophylaxis Based on Ultrasound Results After Total Knee Replacement

Who this might be right for
ThromboembolismArthroplasty Replacement, Knee
University Hospital, Caen 850
Not applicableWithdrawnNCT01523418
What this trial is testing

Study to Observe Safety of Xarelto in VTE Prophlylaxis After Elective TKR (Total Knee Replacement) or THR (Total Hip Replacement)

Who this might be right for
Prophylaxis, Thromboembolism, VenousTotal Knee ReplacementTotal Hip Replacement
Bayer
Large-scale testing (Phase 3)Study completedNCT01431456
What this trial is testing

Safety of DAbigatran and RIvaroxaban Versus NAdroparin in the Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery

Who this might be right for
Venous Thromboembolism
Martini Hospital Groningen 148

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation